Spinal fusion and intra-annular fibrin injection take opposite approaches to chronic back pain — one permanently stabilizes a segment, the other aims to repair it. Here is how they compare on invasiveness, motion preservation, recovery, and candidacy, and what individual evaluation actually means for your decision.

Wondering whether intra-annular fibrin injection might be right for you? This guide explains how candidacy is determined — from MRI findings and prior treatment history to contraindications and what to expect during your ValorSpine evaluation.

Persistent pain after spine surgery may point to unresolved annular tears or adjacent segment changes the original procedure did not address. For many patients with Failed Back Surgery Syndrome, intra-annular fibrin injection offers a non-surgical path that targets disc damage at its source — with candidacy evaluated individually.

Degenerative disc disease does not follow a single treatment path. For some individuals, biologic disc repair and other non-surgical approaches offer meaningful alternatives to spinal fusion — though candidacy depends on each person's anatomy, diagnosis, and prior treatment history.

Epidural steroid injections may reduce inflammation temporarily, but they do not repair disc damage. Intra-annular fibrin injection targets annular tears structurally. Learn how these approaches compare for patients seeking lasting relief from chronic disc-related back pain.

Good ergonomic habits — workspace setup, lifting mechanics, sleep position, and movement breaks — may support spinal recovery after non-surgical disc treatment. Our clinical team covers what to prioritize and why it matters. Individual outcomes vary.

If repeated steroid injections haven't resolved your chronic back or neck pain, the source may be structural disc damage — not inflammation alone. Learn how biologic disc repair with intra-annular fibrin injection targets annular tears and what candidacy evaluation involves.